Related Experiment Video
Updated: Jun 3, 2025

Microwave-Assisted Preparation of 1-Aryl-1H-pyrazole-5-amines
Published on: June 23, 2019
New Benzofuran-Pyrazole-Based Compounds as Promising Antimicrobial Agents: Design, Synthesis, DNA Gyrase B
Somaia S Abd El-Karim1, Manal M Anwar1, Yasmin M Syam1
1Department of Therapeutic Chemistry, Pharmaceutical and Drug Industries Research Institute, National Research Centre, Dokki, Cairo 12622, Egypt.
New benzofuran-pyrazole compounds show significant antimicrobial, antioxidant, and anti-inflammatory properties. Compound 9 effectively inhibits DNA gyrase B, offering potential for new antibiotic development against resistant bacteria.
Area of Science:
- Medicinal Chemistry
- Organic Synthesis
- Antimicrobial Drug Discovery
Background:
- Antibiotic resistance is a growing global health threat.
- Novel antimicrobial agents are urgently needed.
- Benzofuran-pyrazole scaffolds are explored for therapeutic potential.
Purpose of the Study:
- Design, synthesize, and evaluate novel benzofuran-pyrazole hybrid molecules.
- Assess their antimicrobial, antioxidant, and anti-inflammatory activities.
- Investigate their potential as DNA gyrase B inhibitors.
Main Methods:
- Synthesis of benzofuran-pyrazole hybrids via Vilsmeier-Haach reaction.
- Structural confirmation using micro-analytical and spectral techniques.
- Evaluation of antimicrobial, antioxidant, and anti-inflammatory assays, including DNA gyrase B inhibition.
Main Results:
- Compounds 9, 10, 11b-d displayed broad-spectrum antimicrobial activity (MIC 2.50–20 µg/mL).
- Compounds 4, 6, 9, 11b, 11d showed high antioxidant capacity (84.16–90.52% DPPH scavenging).
- Significant anti-inflammatory effects observed (86.70–99.25% HRBC stabilization); Compound 9 inhibited E. coli DNA gyrase B (IC50 9.80 µM).
Conclusions:
- Benzofuran-pyrazole derivatives, especially compound 9, demonstrate significant potential as antimicrobial agents.
- Potent DNA gyrase B inhibition by compound 9 suggests a promising mechanism for combating resistant infections.
- Further development is warranted for clinical applications of these novel compounds.
More Related Videos
10:42Preparation of N-2-alkoxyvinylsulfonamides from N-tosyl-1,2,3-triazoles and Subsequent Conversion to Substituted Phthalans and Phenethylamines
Published on: January 3, 2018
07:50Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments
Published on: October 25, 2024
Related Concept Videos
Sedatives and Hypnotics Drugs: Benzodiazepines
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Anxiolytic Drugs: Benzodiazepines and Buspirone
Electrophilic Aromatic Substitution: Fluorination and Iodination of Benzene
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Aryldiazonium Salts to Azo Dyes: Diazo Coupling